Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer

Completed

• Conditions: Extensive Stage Small Cell Lung Cancer

• Registration Number: NCT05055999
• Lead Sponsor: Hunan Province Tumor Hospital

Brief Summary

The purpose of the trial is to detect tumor microenvironment on Extensive Stage Small Cell Lung Cancer with simultaneous liver metastases who Treated with Atezolizumab plus Etoposide and Platinum Based Chemotherapy.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-04
• Study Start: 2019-04-01
• Primary Completion: 2021-07-01
• Study Completion: 2021-09-01
• Study First Submitted: 2021-09-15
• Study First Submitted QC: 2021-09-15
• Study First Posted: 2021-09-24
• Last Update Submitted: 2022-01-22
• Last Update Posted: 2022-01-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 18， Extensive Stage Small Cell Lung Cancer Confirmed by Histopathology Treated with Atezolizumab plus Etoposide and Platinum Based Chemotherapy

Exclusion Criteria

• Patients with contraindication of chemotherapy Pregnant or breast feeding women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PFS	April 2019- July 2021	Progression free survival
OS	April 2019- July 2021	Overall survival

Trial Locations

Locations (1)

Hunan Cancer Hospital; 🇨🇳 Changsha, Hunan, China